Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Subscribe To Our Newsletter & Stay Updated
